The Boston Keratoprosthesis Type I in Mucous Membrane Pemphigoid
Authors:
- 1 July 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Cornea
- Vol. 32 (7) , 956-961
Abstract
Purpose: To evaluate the use of the Boston keratoprosthesis type I implantation in patients with mucous membrane pemphigoid (MMP). Methods: Retrospective review of 8 eyes of 8 patients with severe ocular surface disease and corneal blindness as a result of MMP who underwent Boston keratoprosthesis type I implantation at the Massachusetts Eye and Ear Infirmary from January 1, 2000, through December 31, 2009. The main outcome measures were best-corrected visual acuity, keratoprosthesis retention, and postoperative complications. Results: The mean age of patients was 71.3 years (range, 55–94 years), and the mean duration of their disease preoperatively was 6.1 years (range, 1.7–11.4 years). Visual acuity after the surgery improved to 20/200 or better in 6 eyes (75%) and to 20/40 or better in 3 eyes (37.5%). Only 1 of 6 eyes (16.7%) was able to maintain visual acuity of 20/200 or better over a mean follow-up period of 3.2 years. Five of the 8 Boston keratoprosthesis type I devices (62.5%) extruded or had to be replaced during a mean follow-up time of 1.7 ± 1.7 years. Loss of vision to worse than 20/200 during the follow-up period occurred because of keratoprosthesis type I extrusion, end-stage glaucoma, and retinal or choroidal detachment. Conclusions: The clinical outcomes of Boston keratoprosthesis type I implantation in MMP are guarded and, as judged from the literature, less favorable than those with the Boston keratoprosthesis type II for the same disease.Keywords
This publication has 25 references indexed in Scilit:
- International Results with the Boston Type I KeratoprosthesisOphthalmology, 2012
- Ocular Cicatricial Pemphigoid: A Review of Clinical Features, Immunopathology, Differential Diagnosis, and Current ManagementSeminars in Ophthalmology, 2011
- Boston Keratoprosthesis Outcomes and ComplicationsCornea, 2009
- Boston Type 1 Keratoprosthesis: The University of California Davis ExperienceCornea, 2009
- Outcomes of Boston Keratoprosthesis in Aniridia: A Retrospective Multicenter StudyAmerican Journal of Ophthalmology, 2007
- Advances in Boston Keratoprosthesis: Enhancing Retention and Prevention of Infection and InflammationInternational Ophthalmology Clinics, 2007
- Results from the Multicenter Boston Type 1 Keratoprosthesis StudyOphthalmology, 2006
- The First International Consensus on Mucous Membrane PemphigoidArchives of Dermatology, 2002
- Okuläres vernarbendes PemphigoidDer Ophthalmologe, 2000
- Penetrating Keratoplasty in Cicatrizing Conjunctival DiseasesOphthalmology, 1995